Open AccessCholecalciferol Plus Calcium Suppresses Abnormal PBMC Reactivity in Patients with Multiple Sclerosis
Author(s) -
Samantha Kimball,
Reinhold Vieth,
HansMichael Dosch,
Amit BarOr,
Roy K. Cheung,
Donald Gagné,
Paul O’Connor,
Cheryl D’Souza,
Melanie R. Ursell,
Jodie Burton
Publication year - 2011
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-0325
Subject(s) - vitamin d and neurology , cholecalciferol , peripheral blood mononuclear cell , medicine , multiple sclerosis , immune system , antigen , gastroenterology , vitamin d deficiency , endocrinology , immunology , in vitro , biology , biochemistry
The active metabolite of vitamin D, 1,25-dihydroxyvitamin D [1,25(OH)(2)D], is a potent modulator of immune cells in vitro.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom